These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 4083212

  • 21. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF, Aramendía JM, Alonso G, Foncillas JG, Brugarolas A.
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [Abstract] [Full Text] [Related]

  • 22. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Interferon alpha and gamma in the treatment of renal cell carcinoma].
    Kawai K, Sato K, Nishijima Y, Sasaki A, Yamashita J, Ishikawa H, Koiso K.
    Nihon Jinzo Gakkai Shi; 1990 Feb; 32(2):231-6. PubMed ID: 2112656
    [Abstract] [Full Text] [Related]

  • 28. Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma.
    Tatsugami K, Eto M, Harano M, Hamaguchi M, Miyamoto T, Morisaki T, Furue M, Akashi K, Naito S.
    Int J Urol; 2008 Aug; 15(8):694-8. PubMed ID: 18564205
    [Abstract] [Full Text] [Related]

  • 29. Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma.
    Rinehart JJ, Malspeis L, Young D, Neidhart JA.
    J Biol Response Mod; 1986 Aug; 5(4):300-8. PubMed ID: 3090208
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
    Hofmockel G, Wirth MP, Heimbach D, Frohmüller HG.
    Urologe A; 1993 Jul; 32(4):290-4. PubMed ID: 8372410
    [Abstract] [Full Text] [Related]

  • 33. [Immunological assessment after radical nephrectomy for renal cell carcinomas pre-treated with interferon-gamma].
    Onishi T, Machida T, Masuda F, Igarashi H.
    Hinyokika Kiyo; 1991 Jul; 37(7):671-8. PubMed ID: 1927765
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.
    Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, Atkins MB.
    Clin Cancer Res; 2000 May; 6(5):1678-92. PubMed ID: 10815886
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Combination therapy with interferon-alpha and continuous infusion of 5-fluorouracil for advanced renal cell carcinoma].
    Noguchi S, Shuin T, Kubota Y, Masuda M, Yao M, Hosaka M.
    Hinyokika Kiyo; 1995 Jul; 41(7):517-20. PubMed ID: 7668181
    [Abstract] [Full Text] [Related]

  • 39. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K, Mura M, Deguchi N, Baba S, Jitsukawa S, Nakazono M, Tazaki H.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
    [Abstract] [Full Text] [Related]

  • 40. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
    Atzpodien J, Kirchner H, Poliwoda H.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():38-43. PubMed ID: 8692118
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.